Triazolam
10 NDCs across 4 manufacturers|8 Generic,2 Brand
Triazolam is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Nov 15, 1982, and the first generic was approved Mar 25, 1994. FDA's Orange Book lists 6 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $4 million on Triazolam across 98,000 claims for 43,000 beneficiaries.
Triazolam is available as 10 NDCs from 4 manufacturers (8 generic, 2 brand), with NADAC prices from $0.26 to $5.32 per EA — the most expensive product costs about 20× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
10
8G / 2B
Manufacturers
4
competing in market
Price Spread
$0.26 – $5.32
per EA
7d Activity
avg -0.7% WoW · of 10 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Mylan Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Benzodiazepine class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
4 manufacturers producing TRIAZOLAM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
HALCION 0.25 MG TABLET | $5.3212 per EA | — |
HALCION 0.25 MG TABLET | $5.3212 per EA | — |
TRIAZOLAM 0.25 MG TABLET | $0.3084 per EA | +2.39% |
TRIAZOLAM 0.25 MG TABLET | $0.3084 per EA | +2.39% |
TRIAZOLAM 0.25 MG TABLET | $0.3084 per EA | +2.39% |
TRIAZOLAM 0.25 MG TABLET | $0.3084 per EA | +2.39% |
TRIAZOLAM 0.25 MG TABLET | $0.3084 per EA | +2.39% |
TRIAZOLAM 0.125 MG TABLET | $0.2628 per EA | -5.83% |
TRIAZOLAM 0.125 MG TABLET | $0.2628 per EA | -5.83% |
TRIAZOLAM 0.125 MG TABLET | $0.2628 per EA | -5.83% |
Frequently Asked Questions
What is Triazolam used to treat?
Triazolam is used to treat sleep initiation and maintenance disorders, per the National Library of Medicine's MED-RT classification.
When did Triazolam become available as a generic?
FDA approved the first generic Triazolam (ANDA) on Mar 25, 1994. The Orange Book currently lists 6 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Triazolam?
In 2024, Medicare Part D spent $4 million on Triazolam across 98,000 claims for 43,000 beneficiaries.
How many Triazolam products are on the market?
The Triazolam drug market contains 10 NDCs from 4 manufacturers — 8 generic and 2 brand products.
What is the price range for Triazolam?
NADAC reference prices for Triazolam range from $0.2628 to $5.3212 per EA — the most expensive product costs about 20× the cheapest.
Is generic Triazolam cheaper than brand?
The average generic NADAC for Triazolam is $0.2913 per EA, versus $5.3212 for brand-labeled products — brand versions average about 18× the generic price.
Which manufacturers make Triazolam?
4 manufacturers list Triazolam in NADAC. Ranked by number of NDCs, the largest are Mylan Pharmaceuticals Inc. (3), Zydus Pharmaceuticals (USA) Inc. (3), Pharmacia & Upjohn Company LLC (2), Ingenus Pharmaceuticals LLC (2).
How has the price of Triazolam changed recently?
Over the past 7 days, 5 Triazolam NDCs rose and 3 fell, with a market-wide average change of -0.7%.